ERBB2 and neoplasm: These results led us to speculate that under normal conditions, spontaneous p53LOH in heterogeneous H/+;ErbB2 tumor population provides a competitive growth advantage to H/−;ErbB2 cells by two complementary mechanisms: the ablation of basal p21 expression via loss-of-function mechanism and stabilization of mutp53 protein enabling its GOF activities.